• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Antech Diagnostics Acquires Leading Canadian Animal Reference Laboratory, Biovet

Share:

October 29, 2019

Antech Diagnostics, part of Mars Petcare, announced its acquisition of Saint Hyacinthe, Quebec-based Biovet, a biotechnology company providing unique expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally. The acquisition expands access to Antech Diagnostics’ innovative diagnostics and comprehensive laboratory services to veterinarians across Canada. As a Canadian leader in animal diagnostics, Biovet contributes extensive R&D assets to Antech’s innovation engine, supporting its focus on driving diagnostic advancements in animal health.

Founded in 1991, Biovet operates a USDA- and CFIA-certified laboratory with a long history of serving veterinarians across Canada. As part of Antech, Biovet will continue to provide clients with excellent reference laboratory services in addition to expanded access to innovative diagnostics, including Antech’s new predictive diagnostic tool, RenalTech, which can predict the onset of chronic kidney disease in cats two years before onset. Biovet President and CEO René Lallier will continue to lead Biovet operations as general manager, managing its team of scientists and laboratory service professionals.

“For nearly three decades, Biovet has led Canada in high-quality laboratory services and diagnostic innovation,” said René Lallier, DVM, MBA, general manager of the new Biovet division of Antech. “Joining with Antech is a natural blend of two like-minded organizations with a shared commitment to delivering innovation and quality to veterinarians, allowing them to deliver excellent, compassionate care to pets.”

“We’re very pleased to welcome Biovet’s employees and customers to the Antech family,” said Mary Kurian, chief operating officer, Antech Diagnostics. “Biovet’s expertise in food and companion animal diagnostics both complements and enhances Antech’s strengths, accelerating our ability to expand services to veterinarians across North America. Biovet’s rich R&D pipeline will enhance our own, which translates to innovative new products and services that help veterinarians keep pets healthy.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: PR Newswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Saint-Gobain Life Sciences Acquires Equflow B.V.Saint-Gobain Life Sciences Acquires Equflow B.V.
  • Health Note Raises $17M for Pre-Clinical Intake Automation PlatformHealth Note Raises $17M for Pre-Clinical Intake Automation Platform
  • Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell TherapiesKite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies
  • Infermedica Launches Ai Feature to Connect Patients with SpecialistsInfermedica Launches Ai Feature to Connect Patients with Specialists
  • Why Life Image regards imaging data as the missing link in AI adoption for healthcareWhy Life Image regards imaging data as the missing link in AI adoption for healthcare
  • Sartorius Stedim Biotech to Acquire Novasep’s Chromatography Process Equipment DivisionSartorius Stedim Biotech to Acquire Novasep’s Chromatography Process Equipment Division
  • Medtronic Acquires KlueMedtronic Acquires Klue
  • ABcellera and Lilly to Co-Develop Antibody Therapies for the Treatment of COVID-19ABcellera and Lilly to Co-Develop Antibody Therapies for the Treatment of COVID-19

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications